Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 1
2005 4
2006 3
2007 3
2008 2
2009 1
2010 2
2011 6
2012 9
2013 8
2014 14
2015 14
2016 23
2017 16
2018 12
2019 11
2020 15
2021 17
2022 14
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year

Filters applied: . Clear all
Page 1
Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts using a Humanized anti-Fibroblast Activation Protein Antibody.
Kobayashi T, Noma K, Nishimura S, Kato T, Nishiwaki N, Ohara T, Kunitomo T, Kawasaki K, Akai M, Komoto S, Kashima H, Kikuchi S, Tazawa H, Shirakawa Y, Choyke PL, Kobayashi H, Fujiwara T. Kobayashi T, et al. Among authors: tazawa h. Mol Cancer Ther. 2024 Apr 18. doi: 10.1158/1535-7163.MCT-23-0527. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38638034
Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity.
Akai M, Noma K, Kato T, Nishimura S, Matsumoto H, Kawasaki K, Kunitomo T, Kobayashi T, Nishiwaki N, Kashima H, Kikuchi S, Ohara T, Tazawa H, Choyke PL, Kobayashi H, Fujiwara T. Akai M, et al. Among authors: tazawa h. Br J Cancer. 2024 Mar 30. doi: 10.1038/s41416-024-02639-1. Online ahead of print. Br J Cancer. 2024. PMID: 38555315
Fluorescence-guided assessment of bone and soft-tissue sarcomas for predicting the efficacy of telomerase-specific oncolytic adenovirus.
Uotani K, Tazawa H, Hasei J, Fujiwara T, Yoshida A, Yamakawa Y, Omori T, Sugiu K, Komatsubara T, Kondo H, Morita T, Kiyono M, Yokoo S, Hata T, Kunisada T, Takeda K, Urata Y, Fujiwara T, Ozaki T. Uotani K, et al. Among authors: tazawa h. PLoS One. 2024 Feb 20;19(2):e0298292. doi: 10.1371/journal.pone.0298292. eCollection 2024. PLoS One. 2024. PMID: 38377118 Free PMC article.
Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus.
Hashimoto M, Kuroda S, Kanaya N, Kadowaki D, Yoshida Y, Sakamoto M, Hamada Y, Sugimoto R, Yagi C, Ohtani T, Kumon K, Kakiuchi Y, Yasui K, Kikuchi S, Yoshida R, Tazawa H, Kagawa S, Yagi T, Urata Y, Fujiwara T. Hashimoto M, et al. Among authors: tazawa h. Br J Cancer. 2024 Apr;130(7):1187-1195. doi: 10.1038/s41416-024-02583-0. Epub 2024 Feb 5. Br J Cancer. 2024. PMID: 38316993 Free PMC article.
176 results